PELEUS Trademark

Trademark Overview


On Monday, March 26, 2018, a trademark application was filed for PELEUS with the United States Patent and Trademark Office. The USPTO has given the PELEUS trademark a serial number of 87850414. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2019. This trademark is owned by Achilles Therapeutics Limited. The PELEUS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes

Bioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease

Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies

Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featu...

Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
peleus

General Information


Serial Number87850414
Word MarkPELEUS
Filing DateMonday, March 26, 2018
Status700 - REGISTERED
Status DateTuesday, May 7, 2019
Registration Number5743057
Registration DateTuesday, May 7, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements


Goods and ServicesMedical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
Goods and ServicesBioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease
Goods and ServicesCustom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies
Goods and ServicesScientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; providing a bioinformatics platform featuring computer software for identifying clonal neoantigens
Goods and ServicesMedical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameACHILLES THERAPEUTICS UK LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressLONDON W6 8PW
GB

Party NameAchilles Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12FX

Party NameAchilles Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12FX

Party NameAchilles Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12FX

Trademark Events


Event DateEvent Description
Wednesday, August 4, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 7, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 28, 2018EXAMINER'S AMENDMENT ENTERED
Friday, December 28, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 28, 2018EXAMINERS AMENDMENT E-MAILED
Friday, December 28, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, December 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 11, 2018NON-FINAL ACTION E-MAILED
Wednesday, July 11, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 10, 2018ASSIGNED TO EXAMINER
Tuesday, May 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 29, 2018NEW APPLICATION ENTERED IN TRAM